Innovent Biologics Inc
Company Profile
Business description
Innovent Biologics, or Innovent, is one of the leading biotechnology companies in China. Listed on the Hong Kong Exchange in 2018, Innovent has eight commercialized oncology products and two commercialized non-oncology products as of August 2023. Its core asset is Tyvyt, a PD-1 inhibitor included in the National Reimbursement Drug Lists for the first-line treatment of five major cancers. Innovent has over 30 strategic collaborations with global pharmaceutical or biotech companies, such as Eli Lilly, Roche Group, Incyte, and others. It also has a wide spectrum of therapeutic targets in early clinical developments. Among its upcoming pipelines, the potential blockbuster is Mazdutide, a therapy for obesity and type 2 diabetes.
Contact
168 Dongping Street
Suzhou Industrial Park, Jiangsu
Suzhou 215123
CHNT: +86 51269566088
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
4,872
Innovent Biologics Inc News & Analysis
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 7,897.50 | 48.10 | 0.61% |
CAC 40 | 7,923.81 | 9.16 | 0.12% |
DAX 40 | 17,945.44 | 48.94 | 0.27% |
Dow JONES (US) | 38,225.66 | 322.37 | 0.85% |
FTSE 100 | 8,197.56 | 25.41 | 0.31% |
HKSE | 18,475.20 | 268.07 | 1.47% |
NASDAQ | 15,840.96 | 235.48 | 1.51% |
Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
NZX 50 Index | 11,938.08 | 64.04 | 0.54% |
S&P 500 | 5,064.20 | 45.81 | 0.91% |
S&P/ASX 200 | 7,629.00 | 42.00 | 0.55% |
SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sigma Healthcare Ltd SIG | 1.30 | 0.04 | 3.19% |
South32 Ltd S32 | 3.58 | 0.03 | 0.85% |
Telstra Group Ltd TLS | 3.58 | 0.01 | -0.28% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.13% |
Zip Co Ltd ZIP | 1.29 | 0.05 | 3.63% |
Red 5 Ltd RED | 0.43 | 0.01 | -1.16% |
Alumina Ltd AWC | 1.56 | 0.04 | 2.30% |
Pilbara Minerals Ltd PLS | 4.18 | 0.12 | 2.96% |
The Star Entertainment Group Ltd SGR | 0.44 | 0.03 | 6.10% |
Evolution Mining Ltd EVN | 3.73 | 0.22 | -5.57% |